Bausch Health Companies Inc. (BHC)

Business: Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology.

IPO Date: 29-Mar-1994

CEO & Director: Mr. Thomas J. Appio

U.S. Pres of Pharma Bus.: Mr. Robert A. Spurr

Listing: NYSE: BHC

Country: Canada

Headquarters: Laval, QC

Website: https://www.bauschhealth.com

Market cap: $2,673.10 Mln

Revenue (TTM): $8,325.00 Mln

Earnings (TTM): $-407.00 Mln

Cash: $1,249.00 Mln

Total Debt: $23,168.00 Mln

Insider's Holding: 2.87%

Liquidity: Low

52 Week range: $6.89 - 30.30

Shares outstanding: 361,480,000

10 Years Aggregate:

• CFO: $16,109.64 Mln
• EBITDA: $21,463.32 Mln
• Net Profit: $-7,809.37 Mln